Susanne Saussele, MD, University of Heidelberg, Germany, emphasizes the need to monitor patients with CML and additional chromosomal abnormalities. This is important to determine whether the additional chromosomal abnormalities respond to TKI treatment. If not, stem cell transplant should be considered.